AzTrials
AzTrials

Research institution

RenJi Hospital Clinical Trials

Studies where RenJi Hospital is the lead sponsor: what is enrolling now, by phase, condition and country.

553 registered studies

In numbers

Open to volunteers
163
Active
176
With results posted
4
All registered
553

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 163
  • Autosomal Dominant Polycystic Kidney

    GBP-213 in Patients With Autosomal Dominant Polycystic Kidney Disease

    • Not yet recruiting
    • Age: 18 to 65 years
    • Early Phase 1

    This study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of GBP-213 in patients with autosomal dominant polycystic kidney disease (ADPKD).

    Trial name
    NCT07891364
    Testing
    GBP-213
    Where
    China
    Volunteers
    24 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT07891364
  • Renal Cell Carcinoma, Benign Renal Mass

    Plasma DNA Methylation for Preoperative Classification of Renal Masses

    • Recruiting
    • Age: 18 years and older
    • Observational study

    METH-RENAL is a prospective observational diagnostic development and threshold-setting study in adults with a renal mass scheduled for partial or radical nephrectomy.

    Trial name
    NCT07874542
    Where
    China
    Volunteers
    240 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT07874542
  • Deep Vein Thrombosis

    PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis

    • Recruiting
    • Age: 18 to 85 years
    • Surgery or procedure

    Patients with iliofemoral vein thrombosis are prone to developing post-thrombotic syndrome (PTS). The profunda femoris vein (PFV) is an important inflow of the iliofemoral vein.

    Trial name
    NCT07622199
    Testing
    Endovascular treatment with profunda femoris vein thrombosis clearance (Endovascular treatment with PFV-TC), Percutaneous mechanical thrombectomy without profunda femoris vein thrombosis clearance (PMT without PFV-TC)
    Where
    China
    Volunteers
    140 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT07622199
  • Prostate Biopsy, Sedation Complication

    Effect of Remimazolam on Hypoxemia and/or Hypotension in Prostate Biopsy

    • Not yet recruiting
    • Age: 65 to 80 years

    This study aims to investigate whether remimazolam, a novel benzodiazepine sedative, can reduce the composite incidence of hypotension and hypoxemia during prostate biopsy in elderly patients compared with propofol.

    Trial name
    NCT07854197
    Testing
    Using remimazolam for sedation during prostate biopsy, Administer 1.5mg/kg of propofol for sedation
    Volunteers
    1,146 people
    Sponsor
    RenJi Hospital
  • Multiple Myeloma

    Long-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012F Injection

    • Not yet recruiting
    • Age: All ages
    • Observational study

    This is an open-label, multicenter, observational study (non-interventional study) to evaluate the long-term safety, efficacy, and in vivo pharmacokinetic persistence of CAR-T cells in subjects treated with GC012F Injection

    Trial name
    NCT07833046
    Testing
    No Intervention: Observational Cohort
    Where
    China
    Volunteers
    40 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT07833046
  • Tirzepatide, Frozen Embryo Transfer

    Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

    • Not yet recruiting
    • Age: 20 to 40 years

    To evaluate the efficacy and safety of Dual GIP/GLP-1 receptor agonist pretreatment on reproductive outcomes in obese women before frozen embryo transfer.

    Conditions
    Tirzepatide, Frozen Embryo Transfer, Obesity
    Trial name
    NCT07811895
    Testing
    Dual GIP/GLP-1 receptor agonist
    Where
    China
    Volunteers
    1,510 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT07811895
  • Central Nervous System Infections

    Safety and Efficacy of Ventricular Irrigation for Ventriculitis

    • Recruiting
    • Age: 18 to 65 years
    • Surgery or procedure

    Ventriculitis is a severe infectious disease of the central nervous system with diverse etiologies. Currently, the treatment for ventriculitis is challenging, with poor prognosis.

    Trial name
    NCT06358209
    Testing
    Ventricular irrigation
    Where
    35 sites in China
    Volunteers
    310 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT06358209
  • Esophageal Squamous Cell Cancer

    Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC

    • Not yet recruiting
    • Age: 18 to 75 years
    • Surgery or procedure

    The goal of this clinical trial is to evaluate the efficacy and safety of retlirafusp alfa combined with radical chemoradiotherapy in the treatment of locally advanced unresectable esophageal squamous cell carcinoma.

    Trial name
    NCT07769866
    Testing
    Induction chemo-immunotherapy, Concurrent chemoradiotherapy (cCRT), maintenance immunotherapy
    Where
    China
    Volunteers
    68 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT07769866
  • Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Postoperative Pain

    FICB for Hip Fracture Pain in Elderly

    • Not yet recruiting
    • Age: 65 years and older
    • Surgery or procedure

    Hip fracture is a common injury in elderly patients, often requiring surgical treatment. However, these patients frequently experience severe postoperative pain, which can delay mobility and recovery, and increase the risk of…

    Conditions
    Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Postoperative Pain, QoR-15, Fascia Iliaca Block
    Trial name
    FICB-PREP (NCT07762846)
    Testing
    Ultrasound-Guided Fascia Iliaca Compartment Block
    Where
    China
    Volunteers
    144 people
    Sponsor
    RenJi Hospital
    Can I take part? FICB-PREP
  • Prostate Cancer, Circulating Tumor Cell

    A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients

    • Recruiting
    • Age: 18 to 75 years
    • Observational study
    • Medical device

    The goal of this observational study is to compare the number of CTCs enriched by both sampling methods, leukapheresis and collection of peripheral blood in metastatic prostate cancer patients.

    Conditions
    Prostate Cancer, Circulating Tumor Cell, Leukapheresis
    Trial name
    NCT06469710
    Testing
    leukapheresis
    Where
    China
    Volunteers
    50 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT06469710

Completed, with results posted

All 4
  • Haematological Malignancy

    Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation

    • Completed
    • Age: 18 to 75 years
    • Pill or oral medicine
    • Results posted

    Malnutrition is common after haematopoietic stem cell transplantation (HSCT), and is a well-known prognostic factor for survival.

    Trial name
    NCT05460013
    Testing
    Traditional Control, Oral Nutritional Supplement
    Where
    China
    Volunteers
    100 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT05460013
  • Somatization Disorder

    Assessment of Somatic Symptom in Chinese Community-Dwelling People

    • Completed
    • Age: 18 to 100 years
    • Observational study
    • Results posted

    With the rapid aging and worsening psychological problems worldwide, the special focus on somatic symptom and other psychological diseases of the older population is needed.

    Trial name
    NCT04815863
    Testing
    Assessment of somatic symptom disorder with SSS-CN, Assessment of depressive symptoms disorder with PHQ-9, Assessment of anxiety disorder with GAD-7
    Where
    2 sites in China
    Volunteers
    9,110 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT04815863
  • Primary Biliary Cholangitis, Cardiovascular Abnormalities

    Early Identification of Myocardial Impairment in PBC

    • Completed
    • Age: 18 to 80 years
    • Observational study
    • Results posted

    Primary biliary cholangitis (PBC) is a chronic inflammatory liver disease leading to cirrhosis. Researches reported patients with PBC may involve abnormalities on skeleton, thyroid and exocrine glands.

    Trial name
    EARLY-MYO-PBC (NCT03545672)
    Testing
    CMR examination
    Where
    China
    Volunteers
    119 people, healthy volunteers welcome
    Sponsor
    RenJi Hospital
  • Dyspepsia, Compliance

    Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

    • Completed
    • Age: 18 to 75 years
    • Phase 4
    • Results posted

    The study hypothesis is appropriate clinician-patient communication that provides explanations of the reasons for psychoactive drug prescriptions based on the generation of FD symptoms and the drugs' effects might improve…

    Conditions
    Dyspepsia, Compliance, Depression
    Trial name
    NCT01851863
    Testing
    Omeprazole, Flupentixol-Melitracen(psychological and GI) + Omeprazole, Flupentixol-Melitracen(psychological) + Omeprazole
    Where
    China
    Volunteers
    262 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT01851863

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in